 |
|
|
|
June 2004 Cover
|
|
Paris-based Aventis, France's largest drug firm, is one step closer in getting US approval for Sculptura, its injectable wrinkle-filling drug for patients with AIDS-related wasting condition.
An advisory panel unanimously voted to recommend Food and Drug Administration approval of Sculptura for people with HIV, while cautioning against more widespread use.
Editor's Note: from the New York Times
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
